Almirall S.A. (BME: ALM), a global pharmaceutical company focused on medical dermatology, today announced the initiation of the phase I study evaluating the safety,...
Spanish biopharmaceutical company, Almirall has announced the appointment of Mercedes Diz as Vice President (VP) of Corporate Strategy.
Diz joined Almirall in 2002 and, since...
Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health has today announced that “It has collaborated with the University of Michigan to...
Almirall S.A. (BME: ALM), a global biopharmaceutical company focused on skin health, launches today its 6th call for proposals to establish collaborations in dermatological...
